Navigation Links
Researchers find melanoma not caused by early UVA light exposure
Date:5/4/2010

HOUSTON Early life exposure to ultraviolet A light does not cause melanoma in a fish model that previously made that connection, scientists from The University of Texas MD Anderson Cancer Center reported today in the online Early Edition of the Proceedings of the National Academy of Sciences.

UVA exposure is unlikely to have contributed to the rise in the incidence of melanoma over the past 30 years, the researchers conclude, because the fish model had been the only animal model to indicate a connection between exposure to UVA at a young age and later development of melanoma.

"Our data refute the only direct evidence that UVA causes melanoma, which is not to say that UVA is harmless," said the study's lead author David Mitchell, Ph.D., professor in M. D. Anderson's Department of Carcinogenesis located at its Science Park Research Division in Smithville, Texas. "UVA is just not as dangerous as we thought because it doesn't cause melanoma."

UVA is a carcinogen responsible for squamous cell carcinomas that also causes premature aging of the skin and suppresses the immune system. It's also possible, the authors note, that long-term chronic exposure to UVA can hasten the progression to malignancy of melanocytes in the skin that are already on the path to becoming melanoma.

Mitchell and colleagues tested the effects of UVA and ultraviolet B (UVB) light exposure in melanoma-prone fish hybrids that develop the disease spontaneously 15-20 percent of the time without exposure to UV light.

The scientists exposed a hybrid form of the genus Xiphophorus, more commonly known as platyfishes and swordtails, to either UVA or UVB daily between their fifth and 10th day of life. The fish were then scored for melanoma 14 months after exposure.

"We found that UVB exposure induced melanoma in 43 percent of the 194 treated fish, a much higher rate than the 18.5 percent incidence in the control group that received no UV exposure," Mitchell said. This was expected because UVB exposure at an early age is a well-established cause of melanoma.

Only 12.4 percent of 282 fish exposed to UVA developed the disease, which is not statistically different from the control group.

An influential 1993 study using the same hybrid fish connected UVA exposure to melanoma. Until that study, Mitchell said, sunscreens protected only against UVB exposure, which was of immediate public health concern because UVA makes up 90 percent of the ultraviolet light spectrum of sunlight.

"The thought was that people who used sunscreen stayed out in the sun longer, absorbing a higher dose of UVA, causing a higher risk for melanoma" Mitchell said. Most sunscreens now protect against UVA. However, the increase in the incidence of melanoma has been thought to be partly attributable to childhood exposure to UVA back when sunscreens blocked only UVB. That's unlikely, given the new results, Mitchell said.

The 1993 experiment could not be replicated in mammalian models of melanoma, Mitchell said, and a statistical retrospective of the 1993 paper indicated problems with sample sizes that were too small to yield a definitive answer on UVA exposure.

So, Mitchell and colleagues conducted the experiment again, with much larger sample sizes that provided the statistical power to reach stronger conclusions.

They also stratified the melanomas found in each group by severity, with the control and UVB-exposed fish having a higher incidence of severe, stage IV disease, while those exposed to UVA had significantly more early stage melanomas.

UVB exposure damages DNA directly, while UVA is thought to inflict its damage indirectly by inducing melanin free radicals that react with DNA to form oxidative damage that leads to melanoma. Previous studies had shown a correlation between melanin radical formation and melanoma in the UVA range of the solar spectrum. Since Mitchell and colleagues found no connection between UVA and melanoma, they note that the role of melanin free radicals in this disease is brought into question.


'/>"/>

Contact: Scott Merville
smerville@mdanderson.org
713-792-0661
University of Texas M. D. Anderson Cancer Center
Source:Eurekalert

Related biology news :

1. Researchers identify proteins involved in new neurodegenerative syndrome
2. Texas researchers and educators head for Antarctica
3. MGH researchers describe new way to identify, evolve novel enzymes
4. University of Pennsylvania researchers develop formula to gauge risk of disease clusters
5. U of MN researchers discover noninvasive diagnostic tool for brain diseases
6. U of Minnesota researchers discover noninvasive diagnostic tool for brain diseases
7. Researchers discover new strategies for antibiotic resistance
8. Researchers find new taste in fruit flies: carbonated water
9. Binghamton University researchers investigate evolving malaria resistance
10. UIC researchers find promising new targets for antibiotics
11. Researchers develop simple method to create natural drug products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... -- In vitro diagnostic (IVD) companies were very active in ... Kalorama Information expects that trend to continue – though ... uncertainty in reimbursement and healthcare reform in ... acquisitions landscape. Instead of looking to buy technology, the ... of their home country and also to increase their ...
(Date:1/13/2017)... PORT WASHINGTON, N.Y. , Jan. 13, 2017 ... provider of technology solutions for the homecare industry, ... appointment of homecare industry expert, Justin Jugs, as ... Justin brings more than 15 years of homecare ... the team in developing strategic plans to align ...
(Date:1/12/2017)...  New research undertaken by Fit Small Business ... participants were simply asked which office technology had they not ... standard issue.  Insights on what will be key ... futurists and industry leaders including Penelope Trunk , ... Some of these findings included; ...
Breaking Biology News(10 mins):
(Date:1/19/2017)... Research and Markets has announced the addition of the ... Global Opportunity Analysis and Industry Forecast, 2014-2022" report to their ... Cancer ... reach $15,737 million by 2022 from $6,521 in 2015, growing at ... Omic technologies segment accounted for more than half of the revenue ...
(Date:1/19/2017)... and HOUSTON , Jan. ... Prenatal") today announced the formation of its Medical/Clinical ... clinicians and industry veterans who enhance the range ... it accelerates development of its novel prenatal diagnostic ... medical, clinical and strategic guidance for the company,s ...
(Date:1/19/2017)... , Jan 19, 2017 Research and Markets ... has announced the addition of the ... Application - Forecast to 2025" report to their offering. ... The report provides a detailed analysis on current and future ... till 2025, using estimated market values as the base numbers ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... software to leading biopharmaceutical and medical device manufacturers and regulators, is proud to ... CFR Part 11-compliant email client designed to provide product vigilance departments with the ...
Breaking Biology Technology: